Kite Pharma, Inc.: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2016)
- $22.2M
- Net Income/Loss (FY2016)
- -$267.1M
- Total Assets (FY2016)
- $524.3M
- Total Equity (FY2016)
- $428.0M
- Cash Flows from Operating Activities (FY2016)
- -$168.9M
Source: Kite Pharma, Inc. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
